Trium Capital LLP has filed its 13F form on August 11, 2025 for Q2 2025 where it was disclosed a total value porftolio of $830 Million distributed in 56 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci Canada ETF with a value of $71.7M, Spring Works Therapeutics, Inc. with a value of $37M, Albertsons Companies, Inc. with a value of $32.1M, Blueprint Medicines Corp with a value of $30.8M, and Kraneshares Tr Csi China Inter with a value of $30.2M.

Examining the 13F form we can see an increase of $29.2M in the current position value, from $801M to 830M.

Trium Capital LLP is based out at London, X0

Below you can find more details about Trium Capital LLP portfolio as well as his latest detailed transactions.

Portfolio value $830 Million
ETFs: $627 Million
Healthcare: $88.1 Million
Consumer Defensive: $32.1 Million
Consumer Cyclical: $23.3 Million
Technology: $20.4 Million
Industrials: $18.2 Million
Real Estate: $8.72 Million
Energy: $7.85 Million
Other: $4.39 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 56
  • Current Value $830 Million
  • Prior Value $801 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 11, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 25 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Trium Capital LLP Portfolio

Follow Trium Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trium Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Trium Capital LLP with notifications on news.